Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer [NA]
This document summarizes a completed clinical trial evaluating gefitinib for metastatic or unresectable head and neck cancer and non-small c…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 randomized trial in non-small cell lung cancer compared PR-104 alone to PR-104 with docetaxel and was terminated with results post…
-
FDA approval · 2013-01-09FDA Approved: VINORELBINE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for Vinorelbine submitted by Sagent Pharmaceuticals, making a generic version of the cancer drug ava…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]
Clinical trial updates show Erlotinib tested in patients with advanced Non-small Cell Lung Cancer, Ovarian Epithelial Cancer, and Head and N…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer [Phase 1]
A Phase 1 clinical trial update announcing completion of a study of the monoclonal antibody ABX-EGF in patients with multiple cancers, inclu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. [Phase 1]
This clinical trial update reports the termination of a Phase I study of AZD1480 in patients with advanced solid malignancies and advanced h…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Iressa Expanded Access Program (EAP) [Phase 3]
Update on AstraZeneca's Iressa (gefitinib) Expanded Access Program in Phase 3 for non-small-cell lung cancer, including metastatic disease, …
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer [Phase 2]
Pfizer-sponsored Phase 2 trial evaluating AG-013736 with cisplatin and gemcitabine in patients with squamous non-small cell lung cancer; the…
-
CLINICAL_TRIALS trial_result · 2013-01-01Clinical Trial Update: A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer [Phase 3]
Phase 3 trial comparing aflibercept plus docetaxel versus placebo plus docetaxel in second-line locally advanced or metastatic non-small cel…
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma [Phase 2]
A Phase 2 trial evaluated docetaxel and gemcitabine with Filgrastim-SD/01 support in patients with advanced non-small cell lung cancer; the …
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating cisplatin and docetaxel with or without radiation therapy in newly diagnosed stage III non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2012-12-25Clinical Trial Update: S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating docetaxel and cetuximab with radiation therapy in stage III non-small cell lung cancer was terminated, with results…
-
CLINICAL_TRIALS research · 2012-12-24Clinical Trial Update: Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC [Phase 2]
Clinical trial evaluating Gefitinib versus Docetaxel as second-line therapy for patients with wild-type EGFR non-small cell lung cancer (Pha…
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III [Phase 2]
This clinical trial update reports the completion of a Phase II study evaluating docetaxel plus cisplatin for stage III non-small cell lung …
-
CLINICAL_TRIALS research · 2012-12-13Clinical Trial Update: Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients [Phase 2]
A Phase 2 trial compares vinorelbine–ifosfamide with gefitinib in EGFR gene mutation–negative non-small cell lung cancer; the status of the …
-
CLINICAL_TRIALS research · 2012-12-12Clinical Trial Update: Epidemiological Study to Describe Non-small-cell Lung Carcinoma (NSCLC) Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA
An epidemiological study describing non-small-cell lung cancer clinical management patterns in the Middle East and North Africa (MENA), focu…
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy [Phase 2]
A Phase 2 clinical trial evaluating intratumoral chemotherapy delivered through a flexible bronchoscope as an adjunct to brachytherapy for n…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma [Phase 2]
Phase 2 study of AVE0005 (aflibercept) in platinum- and erlotinib-resistant locally advanced or metastatic non-small-cell lung cancer has co…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy [Phase 2]
This Phase 2 trial investigates sequencing or combination of chemotherapy with EGFR-TKIs in non-small cell lung cancer patients who failed p…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase I/II safety study of IPI-504 (retaspimycin hydrochloride), an HSP90 inhibitor, in relapsed/refractory stage IIIb or stage IV non-small…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations [Phase 2]
A Phase 2 trial comparing pemetrexed with gefitinib in locally advanced or metastatic non-small cell lung cancer patients who have previousl…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery [Phase 2]
A Phase 2 clinical trial evaluating vandetanib with carboplatin and paclitaxel for resectable stage I–III non-small cell lung cancer was ter…
-
CLINICAL_TRIALS research · 2012-12-07Clinical Trial Update: Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301) [Phase 3]
This clinical trial update notes the completion of a Phase 3 study comparing radiotherapy with vs without carboplatin (CBDCA) in elderly pat…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
A terminated Stanford trial assessed whether real-time Cine-MRI could feasibly guide treatment of moving and deforming tumors in pancreatic …
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial comparing two sequencing regimens for non-small cell lung cancer: docetaxel plus cisplatin followed by gemcitabine versus ge…